Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
ZD 7155 is a nonpeptide antagonist of the angiotensin II type 1 (AT1) receptor (IC50 = 3.3 nM).1 It inhibits angiotensin II-induced pressor responses in conscious normotensive rats in a dose-dependent manner and decreases mean arterial pressure in conscious spontaneously hypertensive rats when administered at a dose of 1.082 µmol/kg.2 ZD 7155 (10 mg/kg in the drinking water) improves motor nerve conduction velocity in the sciatic nerve in a rat model of streptozotocin-induced diabetic neuropathy.3 It decreases disease severity and NF-κB and activator protein 1 (AP-1) activation in a mouse model of LPS-induced acute lung injury when administered at a dose of 10 mg/kg.4
WARNING This product is not for human or veterinary use.
1. Structure of the Angiotensin receptor revealed by serial femtosecond crystallography. Cell 161(4), 833-844 (2015).
2. Comparative cardiovascular effects of the angiotensin II type 1 receptor antagonists ZD 7155 and losartan in the rat. J. Pharm. Pharmacol. 48(8), 829-833 (1996).
3. Nerve function and regeneration in diabetic rats: Effects of ZD-
4. Angiotensin II type-